• Patent Grants
  • Patents which prove CHA Medical Group’s strength in stem cell research

CHA Medical Group’s advanced stem cell technology

CHA Medical Group has filed the following patents related to stem cell and immunocyte research.

No Patent Grants
41 [KR] Methods For Cell Expansion And Uses Of Cells And Conditioned Media Produced Thereby For Therapy (Registration number 10-1490449)
40 [EP] Method for differentiating human neural progenitor cells into dopaminergic neurons, and medium for differentiation thereof (Registration number 02581443)
39 [US] Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof (Registration number 8921107)
38 [KR] Method for producing human embryonic stem cell-derived perivascular progenitor cell and composition for cell therapy comprising the same (Registration number 10-1477016)
37 [KR] Methods for preparing extract of umbilical cord and uses thereof (Registration number 10-1462004)
36 [CN] Process for differentiation of human neural progenitor cells to dopaminergic neurons and medium for differentiation thereof (Registration number 102985535)
35 [KR] Testicular somatic cell-derived multipotent stem cells, process for the preparation thereof, and pharmaceutical composition for treating erectile dysfunction comprising the same
34 [KR] Cell therapy product for cartilage damage comprising collagen, hyaluronic acid derivative and mammalian umbilical cord-derived stem cells (Registration number 10-1422689)
33 [KR] Composition for skin regeneration by using medium or secretion of embryonic stem cell derived endothelial progenitor cells and use thereof (Registration number 10-1422690)
32 [KR] Composition for skin regeneration by using medium or secretion of cord blood derived endothelial progenitor cells(CB-EPCs) and use thereof (Registration number 10-1422453)